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Abstract 
Background. White matter (WM) impairments have been reported in patients with bipolar disorder (BD) and 
those at high familial risk of developing BD. However, the distribution of these impairments has not been well-
characterized. Few studies have examined WM integrity in young people early in the course of illness and in 
individuals at familial risk who have not yet passed the peak age of onset. 
Methods. WM integrity was examined in 63 BD subjects, 150 high risk individuals (HR), and 111 participants 
with no family history of mental illness (CON). All subjects were aged 12 to 30. 
Results. This young BD group had significantly lower fractional anisotropy within the genu of the corpus 
callosum (CC) compared to the CON and HR groups. Moreover, the abnormality in the genu of the CC was 
also present in HR participants with recurrent major depressive disorder (MDD) (n=16) compared to controls. 
Conclusions. Our findings provide important validation of interhemispheric abnormalities in BD patients. The 
novel finding in HR subjects with recurrent MDD - a group at particular risk of future hypo/manic episodes - 
suggests that this may potentially represent a trait marker for BD, though this will need to be confirmed in 
longitudinal follow-up studies. 
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Introduction 
Despite growing evidence for white matter (WM) impairments in bipolar disorder (BD) using diffusion 
tensor imaging (DTI), findings have been inconsistent (Heng et al., 2010, Nortje et al., 2013, Vederine et al., 
2011). Moreover, impaired WM may reflect either genetic liability for the disorder, illness progression or the 
effects of treatment (Hajek et al., 2005). First-degree relatives of patients with BD are at increased risk of 
developing this condition, and recent research has demonstrated strong heritability of WM morphology (Chiang 
et al., 2012). Consequently, studying WM brain abnormalities in individuals at familial risk of developing BD 
may facilitate understanding of biological risk factors predicting the later development of BD. A number of 
studies have revealed both widespread and localized reductions in WM integrity in unaffected relatives of 
patients with BD, but the spatial distribution and extent of these impairments remains uncertain (Versace et al., 
2010, Sprooten et al., 2011, Sprooten et al., 2013, Matsuo et al., 2011, Mahon et al., 2013, Linke et al., 2013, 
Frazier et al., 2007, Emsell et al., 2013, Roybal et al., 2015). For example, whilst lower fractional anisotropy 
(FA) in the corpus callosum (CC) of high-risk and BD individuals compared to controls has been reported by 
Sprooten et al. (Sprooten et al., 2013), another study identified this deficit in BD individuals only (Linke et al., 
2013). Similarly, reduced WM integrity in the superior longitudinal fasciculus of unaffected relatives has been 
reported, but whether this effect is intermediate or comparable to the decrease observed in BD patients remains 
unclear (Frazier et al., 2007, Sprooten et al., 2013), and in the absence of group differences another study 
reported genetic liability to be associated with FA in this tract (Emsell et al., 2013). Among other regions, 
pathways involved in emotion regulation involving fronto-temporal lobes such as temporal associative tracts, 
left orbital frontal tracts, superior longitudinal fasciculus, cingulum (Emsell et al., 2013, Frazier et al., 2007, 
Mahon et al., 2013, Sprooten et al., 2013, Sprooten et al., 2011, Versace et al., 2010), pathways connecting 
fibres to frontal regions such as the internal capsule (Sprooten et al., 2011), and intra-hemispheric tracts of the 
CC responsible for inter-hemispheric communication (Roybal et al., 2015, Sprooten et al., 2013) have been 
implicated in subjects at increased familial risk of developing BD. 
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DTI allows for sensitive exploration of WM microstructural features. FA is perhaps the most widely 
accepted DTI measure and reflects directionally-constrained diffusion of water along nerve fibers (Thomason 
and Thompson, 2011). Tract-based spatial statistics (TBSS) is a popular means of quantifying FA that restricts 
the evaluation of diffusion parameters to a WM skeleton (Smith et al., 2006) and addresses prior 
methodological concerns regarding smoothing and normalization (Jones et al., 2002, Chao et al., 2009). Using 
TBSS, three previous studies have investigated FA in subjects at increased genetic risk of developing BD 
compared to controls (Sprooten et al., 2011, Versace et al., 2010, Roybal et al., 2015). 
A limitation of several studies investigating WM abnormalities in unaffected relatives has been the lack 
of a comparator BD group. The inclusion of such a group enables clarification of whether FA findings in 
unaffected relatives are similar to, or distinct from those with the established condition. Hitherto, few studies 
have investigated (within the same study) FA in patients with established BD, individuals at high genetic risk of 
developing BD, and controls. To our knowledge, only three previous studies have employed TBSS in all three 
groups within the same study, each of which had limitations (Linke et al., 2013, Mahon et al., 2013, Sprooten et 
al., 2013).  Two of these three studies had a modest sample size (Linke et al., 2013, Mahon et al., 2013), and the 
study with the largest sample (n for all groups=170) (Sprooten et al., 2013) recruited unaffected relatives who 
had already passed the typical age of illness onset (<30 years). Using voxel-based analysis (Chaddock et al., 
2009, Frazier et al., 2007), tractography (Emsell et al., 2013), and TBSS (Skudlarski et al., 2013), WM deficits 
have been detected in both psychotic and non-psychotic BD individuals, as well as their unaffected relatives. In 
three of these four studies, the mean age of unaffected relatives was over 30 years, again suggesting that many 
would have already passed the typical onset age of BD illness (Chaddock et al., 2009, Emsell et al., 2013, 
Skudlarski et al., 2013). Furthermore, DTI findings in studies that included all three groups have been 
inconsistent in terms of the location and extent of WM abnormalities 
Here, using TBSS, we compared FA in a large young sample of: i) ‘high risk’ (HR) first-degree 
relatives of patients with BD who have not been diagnosed with BD, ii) patients with BD, and iii) control 
subjects (CON) without a family history of BD or other mental illness. As those HR subjects with recurrent 
major depressive disorder (MDD) are at greatest risk for later development of a manic or hypomanic episode 
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(Hillegers et al., 2005, Duffy, 2010), we also compared this sub-group to both the BD and CON groups. To our 
knowledge, this DTI study comprises both the largest HR sample, and the largest combined sample across all 
three groups to date. 
Method 
Participants 
The sample comprised three groups: i) 111 controls (CON) (defined as subjects with no parent or sibling with 
bipolar I (BD-I) or II (BD-II) disorder, recurrent major depression, schizoaffective disorder, schizophrenia, 
recurrent substance abuse or any past psychiatric hospitalisation; and no parent with a first degree relative who 
had a past mood disorder hospitalisation or history of psychosis); ii) 150 subjects genetically ‘high risk’ for BD 
who had not yet developed this condition (HR)  (defined as children or siblings of a proband with a confirmed 
DSM-IV diagnosis of BD-I or BD-II); and iii) 63 BD subjects (defined as meeting DSM-IV criteria for either 
BD-I or BD-II). All participants were aged between 12 and 30 years. Clinical details of the three groups are 
described elsewhere (Perich et al., 2015). The study was approved by the Human Research Ethics Committee of 
the University of New South Wales, and complied with the guidelines of the Australian National Health and 
Medical Research Council. 
The lifetime or current presence of psychiatric disorders (including depression and anxiety) besides BD 
was not an exclusion factor for either HR or CON subjects. This ecological approach has been used by similar 
studies of individuals at high genetic risk for BD (Nurnberger et al., 2011). All participants are involved in an 
ongoing longitudinal study of individuals at high risk for BD aged 12-30 years. HR and BD participants were 
recruited from families who had previously participated in a BD pedigree molecular genetics study or a 
specialized BD research clinic, or were otherwise recruited from clinicians, mental health consumer 
organisations and other forms of publicity. Control subjects were recruited via print and electronic media, and 
noticeboards in universities and local communities. 
The subjects aged between 12-21 years are involved in a collaborative high-risk study with a U.S. 
consortium headed by Dr John Nurnberger which is based at Indiana University, Johns Hopkins University, 
Washington University in St. Louis, and Michigan University (Nurnberger et al., 2011). As this US-Australian 
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collaboration involves common clinical assessments for participants aged 12-21years, we report separately on 
instruments used for the younger (12-21years) and older (22-30 years) age groups in this sample. Both groups 
shared consensus Best-Estimate DSM-IV current and lifetime diagnoses derived from semi-structured 
diagnostic interviews. Brain imaging studies were only undertaken in the Australian sample. A number of 
functional imaging studies on this BD HR sample have been previously reported (Breakspear et al., 2015, 
Roberts et al., 2013). 
Proband consensus DSM-IV diagnosis was determined by two independent raters following Best 
Estimate methodology (Leckman et al., 1982), using information from the Diagnostic Interview for Genetic 
Studies (DIGS) Version 4, the Family Interview for Genetic Studies (FIGS), and medical records (where 
available). Confidence rating ranges using the Best Estimate Methodology vary from 1-4, where 1 represents 
criteria not met for a diagnosis and 4 represents a definite diagnosis. All diagnoses reported have a confidence 
rating of 3 or 4 (probable or definite). Structured diagnostic interviews were also performed on all HR, CON 
and BD participants. For those aged between 12 and 21 (CON, n=51; HR group, n=92; BD group = 11), an 
adapted version of the Schedule for Affective Disorders and Schizophrenia for School-Age Children – Present 
and Lifetime Version (K-SADS-BP) was developed specifically for use in the US-Australia collaborative study 
of young people at genetic risk for bipolar disorder (Nurnberger et al., 2011). The K-SADS-BP combines items 
from the K-SADS Present and Lifetime Version (Kaufman et al., 1997), and uses extended sections on 
depression, mania and ADHD derived from the Washington University in St Louis K-SADS (WASH-U K-
SADS) to elicit detailed information on pre-pubertal mania, rapid-cycling, attentional and sub-threshold bipolar 
symptoms (Geller et al., 2001). The KSADS-BP was administered to both the child and one parent. For 
participants aged under 21, clinicians completed the Children’s Global Assessment Scale (CGAS). 
For participants aged between 22 and 30 (CON, n=60; HR group, n=58; BD group = 52), the DIGS 
(Version 4) was used to measure the current and lifetime presence of axis I DSM-IV disorders. Consensus 
DSM-IV diagnoses of the HR, BD, and CON subjects were determined by two independent raters with Best 
Estimate methodology (Leckman et al., 1982), using the DIGS, the FIGS and medical records (where 
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available).  For participants aged between 22 and 30, clinicians completed the Global Assessment Scale 
(GAS). 
To assess current mood state, for those aged between 12 and 21, the Children’s Depression Inventory (CDI) 
was used, and for participants aged 22-30 years, the Montgomery-Asberg Depression Rating Scale (MADRS) 
was administered. To assess current manic symptoms the Young Mania Rating Scale (YMRS) (Young et al., 
1978) was used for participants aged 22-30 years. Intellectual ability was assessed with the Wechsler 
Abbreviated Scale of Intelligence (WASI). Participants aged 12-30 completed clinical and neuropsychological 
assessments on the same day as the scan (McCormack et al., 2016). The majority of parental reports using the 
K-SADS were also completed on the same day as the scan. 
MRI acquisition 
Images were acquired with a 3-T Philips Achieva scanner at Neuroscience Research Australia (NeuRA) in 
Sydney with an 8-channel head coil. Two acquisitions of 32 directional DTI data (b =1000 s/mm2 with one 
diffusion weighed b0) were acquired using a single-shot echo planar imaging (EPI) sequence. The imaging 
parameters were as follows: TR=7638 ms, TE=68 ms, 55 slices, slice thickness=2.5 mm, gap=0 mm, 
FOV=240×138×240, acquisition matrix size=96×96, flip angle= 90° with an image time of 4 mins 42 secs per 
acquisition. 
Diffusion tensor imaging processing 
Details of pre-processing and TBSS processing steps are provided in the supplementary methods. For 
skeletonisation and ROI extraction from FA images we followed the ENIGMA-TBSS protocols 
(http://enigma.ini.usc.edu/wp-content/uploads/2014/01/ENIGMA_TBSS_protocol_USC.pdf). We extracted the 
mean FA across the full skeleton and subsequently calculated average FA values bilaterally for twenty-one 
intra-hemispheric and four inter-hemispheric tracts, yielding a total of 46 ROIs. The regions analysed are listed 
in Supplementary Table S1. 
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Statistical analyses 
All statistical analyses were carried out using SPSS v.22 (IBM, Chicago, Illinois).  Socio-demographic 
differences between groups were assessed using univariate analysis of variance (ANOVA) followed by 
pairwise comparisons for multiple comparisons using the least significant difference (LSD) method.  To 
compare tracts of interest across diagnostic groups, generalised estimating equations (GEE) models were used 
as they accommodate within-family correlation arising from the inclusion of siblings from within the same 
family in either the CON, HR or BD groups (families were not split between diagnostic groups). Each base 
GEE model was run with FA of the region of interest (ROI) as the dependent variable, hemisphere (right and 
left) as the within-subject factor, diagnostic group as the between-subject factor (CON, HR, and BD), 
hemisphere x group as an interaction, and age and gender as covariates.  To address whether the relationship 
between age and FA of ROI’s differed between groups, a second set of GEE models were fitted where the age x 
group interaction was also included as an interaction term in the base model.  In order to select the most 
parsimonious model, for ROIs with no significant age x group interaction (p > 0.05) the base model was 
selected. 
Correction for multiple testing of the main effects of group, hemisphere and the group x hemisphere interaction 
was carried out using false-discovery rate (FDR) q values using the Benjamini & Hochberg (1995) method 
(Benjamini and Hochberg, 1995). For each dependent variable we used the most parsimonious model and 
ranked group, hemisphere and group x hemisphere comparisons (group, hemisphere and group x hemisphere 
comparisons for twenty-one intra-hemispheric tracts, and group comparisons for four inter-hemispheric tracts, 
yielding a total of 67 ranked comparisons). We also compared HR subjects with recurrent MDD (HR-rMDD) 
(n=16) against the CON and BD groups where we selected the base models and ranked group, hemisphere and 
group x hemisphere comparisons for twenty-one intra-hemispheric tracts, and group comparisons for four inter-
hemispheric tracts. 
Planned comparisons 
9 
Planned post-hoc comparisons were carried out on tracts that revealed either a significant group effect or group 
x hemisphere interaction after correction for multiple testing: nine group x hemisphere interaction comparisons 
(three between-group differences within the left and right hemispheres respectively, in addition to three 
between-hemisphere differences within each study group), and three between-group comparisons. Planned 
comparisons were carried out using the LSD method, and corrected using (FDR) q values. 
Effects of medication and illness severity 
Separate analyses were performed to determine whether group differences were related to exposure to lithium, 
antidepressants, or antipsychotics. To assess associations between FA and measures of illness severity and 
course, relationships between FA and age of onset of first manic, hypomanic, depressive or any mood episode 
were explored using Pearson’s correlations; and relationships between FA and number of episodes of 
hypomania, mania or depression relationships were explored using Spearman’s correlations (as that data was 
not normally distributed). 
Results 
Demographic and clinical data 
Demographic and clinical data for each group are provided in Tables 1 and 2. The HR participants were slightly 
younger than both the CON and BD participants, whilst the BD group was older than the CON group. On the 
MADRS and YMRS, 22-30 year old BD participants scored significantly higher than both their HR and CON 
counterparts, with no significant differences observed between the latter two groups. Among the 12-21 year old 
participants, the BD group had significantly higher scores on the CDI than both the HR and CON participants. 
Current and lifetime consensus best-estimate DSM-IV diagnoses in all three groups are also detailed in 
Table 2. Chi-square comparisons revealed that the lifetime occurrence of at least one major depressive episode 
(MDE) or any lifetime DSM-IV diagnosis (including recurrent major depressive disorder; rMDD) was 
significantly higher in the HR (p<0.01) compared to the CON group, consistent with prior reports of high-risk 
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populations (Nurnberger et al., 2011, Birmaher B et al., 2009).  There were also significantly higher rates of 
anxiety (p<0.05) and behavioural disorders (p<0.01) amongst HR individuals. 
Of the 150 HR participants, 81.3% had a parent with bipolar disorder and 18.7% had a sibling with 
bipolar disorder. Of the 63 BD subjects, 34 had BD-I (54%) and 29 BD-II (46%). The 324 participants 
belonged to 262 families. 
FA results: Group findings 
The genu of the corpus callosum was the only tract with significant group differences in FA after correction for 
multiple comparisons (see Figure 1A). Pairwise comparison between the groups showed that this effect was 
driven by lower FA in the BD compared to the HR and CON groups (BD<HR p=0.03, BD<CON p=0.003, all 
FDR corrected). There were no FA differences within the BD group between participants with and without 
current lithium treatment, between those with and without current antidepressant treatment, and between those 
with and without current antipsychotic treatment (all p > 0.05 uncorrected). Further, the FA finding remained 
significant when those with current lithium and/or antipsychotic treatment in the BD group, and those with 
current MDE and/or current antidepressant treatment current antidepressant use across all three groups were 
removed (n= 107 CON, 139 HR, 19 BD; Wald χ2=6.41, df=2, p=0.040; BD<CON p=0.025, BD<HR p=0.012; 
FDR corrected pairwise comparisons).Within the BD group, measures of illness severity and course, and mood 
state did not correlate with FA (all p > 0.05). Furthermore, there were no differences between BD-I and BD-II 
patients (all p > 0.05). 
To exclude any potential confounding effect of subjects with lifetime major depressive or other DSM-
IV disorders in the CON group, we repeated analyses after excluding these subjects. The finding of lower FA in 
the genu of the corpus callosum remained significant when we compared CON participants with no prior or 
current depressive episode to our total HR and BD samples (n= 99 CON, 150 HR, 63 BD; Wald χ2=8.63, df=2, 
p=0.013; BD<CON p=0.003, BD<HR p=0.032), and when we compared CON participants without any lifetime 
DSM-IV diagnosis to our total HR and CON sample (n= 79 CON, 150 HR, 63 BD; Wald χ2=8.75, df=2, 
p=0.013; BD<CON p=0.003, BD<HR p=0.035; BD<CON but not BD<HR pairwise comparison survived FDR 
correction). Further, to exclude any effect of prior depressive episodes in the HR sample, we compared CON 
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and HR subjects with no prior or current depressive episodes to our BD sample; the differences remained 
significant (n= 99 CON, 106 HR, 63 BD; Wald χ2=10.09, df=2, p=0.006; BD<CON p=0.002, BD<HR 
p=0.013).  Additionally, there were no significant differences between those with at least one lifetime 
depressive compared to those without, both within the CON (p=0.798) and HR (p=0.455) groups. Likewise, 
there were no significant differences between those with or without a lifetime DSM-IV diagnosis within both 
the CON (p=0.609) and HR (p=0.311) groups. 
There were no significant differences in FA in the genu of the corpus callosum between the total HR and CON 
groups. However, as detailed in the introduction above, when we compared only HR subjects with recurrent 
MDD (HR-rMDD) (n=16) against the CON and BD groups, we found that the HR-rMDD group had lower FA 
in the genu of the corpus callosum compared to CON subjects (Wald χ2=12.53, df=2, p=0.002; BD<CON 
p=0.002, HR-rMDD<CON p=0.012; all FDR corrected) (see Figure 1B). There was no significant difference in 
FA in this tract between the HR-rMDD and BD groups. This finding remained significant when those with 
current lithium and/or antipsychotic treatment in the BD group, and those with current MDE and/or current 
antidepressant use across all three groups were removed (n= 107 CON, 12 HR, 19 BD; Wald χ2=9.21, df=2, 
p=0.010; BD<CON p=0.012, HR-rMDD<CON p=0.038). Group comparisons of all ROIs are detailed in 
Supplementary Table S2. 
Hemisphere results and group x hemisphere interactions 
Hemispheric asymmetries are summarised in Supplementary Table S3 as they are not the focus of this paper. 
None of the ROI FAs showed a group x hemisphere interaction at either the corrected or uncorrected level. 
Supplementary Table S4 summarises all group x hemisphere interactions. 
Group x age interaction 
Only one ROI showed an age x group interaction (for sagittal stratum; p=0.046), hence in the GEE models this 
interaction was only included for the sagittal striatum tract. 
Discussion 
12 
We found reduced WM integrity in the genu of the corpus callosum (CC) of BD patients compared to both 
controls and those at high familial risk in a large and relatively young sample, confirming a number of recent 
reports of reduced WM integrity of the CC in BD (Sprooten et al., 2013, Skudlarski et al., 2013, Linke et al., 
2013, Li et al., 2014, Lagopoulos et al., 2013, Emsell et al., 2013, Bauer et al., 2015, Barysheva et al., 2013, 
Sarrazin et al., 2014, Leow et al., 2013, Sarrazin et al., 2015). Furthermore, and of particular interest, we report 
the novel finding that whilst the overall HR group showed no difference in this tract compared to controls, there 
was reduced WM integrity in the CC of those high-risk individuals with recurrent MDD – a finding which 
remained significant after exclusion of those with a current MDE or antidepressants. This finding is of 
particular relevance, as recurrent MDD in those at familial high risk for BD is a strong clinical predictor of later 
development of hypo/manic episodes (Hillegers et al., 2005, Duffy, 2010), suggesting the possibility that lower 
FA in the genu of the CC may represent a trait marker for BD. 
Previous DTI studies of subjects with BD have reported abnormalities in the shape, network 
organisation, and WM microstructure of the CC (Bellani et al., 2009, Bellani and Brambilla, 2011). A meta-
analysis of CC findings in BD revealed a volumetric reduction in the CC of patients, when compared to 
controls (Arnone et al., 2008). Prior DTI studies have also reported lower FA throughout the CC, whereas 
others have reported lower FA in various localised sub-regions of the CC, in both youth and adults with BD 
compared to controls (Barnea-Goraly et al., 2009, Barysheva et al., 2013, Bauer et al., 2015, Chaddock et al., 
2009, Emsell et al., 2013, Lagopoulos et al., 2013, Li et al., 2014, Linke et al., 2013, Sarrazin et al., 2015, 
Sarrazin et al., 2014, Saxena et al., 2012, Skudlarski et al., 2013, Sprooten et al., 2013, Yurgelun‐Todd et al., 
2007). In accordance with our finding in the genu, four of these studies found significantly reduced FA in the 
genu of the CC of BD subjects early in the course of illness compared to controls (Lagopoulos et al., 2013, 
Saxena et al., 2012, Barnea-Goraly et al., 2009, Leow et al., 2013). We found no association in our BD subjects 
between this FA finding in the genu of the CC and indices of BD illness course and severity, mood state or 
current psychotropic medications, suggesting that this WM abnormality was not secondary to either illness 
course or severity, or medication exposure. This is not surprising given that our BD group represented a young 
population early in the course of their illness, who appeared to be high functioning, as suggested by above-
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average IQ scores (Wechsler, 1999) and average GAS scores of over 70  (Shaffer et al., 1983, Endicott et al., 
1976). 
Relatively few studies have examined WM integrity in the CC of subjects at high familial risk of BD, 
and results have been less consistent than those in patients with established BD. Using voxel-based 
morphometry, genetic liability for BD has been found to be significantly associated with WM deficits in, 
among other regions, the genu of the CC (McDonald et al., 2004). In contrast, in other morphological studies of 
CC size and shape, abnormalities appeared to be disease-related rather than indicative of genetic vulnerability 
(Bearden et al., 2011, Walterfang et al., 2009). In TBSS studies which have included the three groups (controls, 
those at high familial risk of developing BD, and BD subjects), there have been reports of reduced WM 
integrity in the CC of BD patients but not in unaffected relatives (Linke et al., 2013). However, subtle 
significant FA reductions in regions such as the splenium and body of the CC have also been observed in 
unaffected relatives, with more widespread FA reductions evident in BD patients (Sprooten et al., 2013). It is 
noteworthy that the age ranges in the Linke et al. (Linke et al., 2013) and Sprooten et al. (Sprooten et al., 2013) 
studies were 18-65 and 18-70 respectively, suggesting that many participants included as being at familial risk 
of developing BD may have already passed the peak age of onset for BD. Also, in accord with the direction of 
our FA findings, a prior TBSS study that did not include a BD comparison group reported lower FA in one 
large cluster that included the CC in young high-risk individuals aged 12-25 compared to controls (Sprooten et 
al., 2011), whereas in contrast, another TBSS study that also did not include a BD comparison group reported 
increased FA in the body splenium and genu of the CC of children at high-risk of developing BD compared to 
controls (Roybal et al., 2015). 
As our HR group has not yet passed the peak age of onset for developing BD (< 30 years), this group is 
more likely than samples of older subjects to include a higher proportion of individuals who will later convert 
to BD. Although it is not known at the time of this study which of these individuals may later develop BD, 
those who have already developed recurrent MDD have been found in other studies to be at greater risk of 
conversion (Hillegers et al., 2005, Duffy, 2010).  Our novel finding of reduced WM integrity in the genu of the 
CC in those who have already developed recurrent MDD in the HR group raises the question of whether this 
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may represent a biological as well as clinically distinct phenotype that may be at particular high risk of 
ultimately developing BD. 
As the CC is the largest WM fiber tract that connects the brain hemispheres, facilitating communication 
between left- and right-side brain structures (De Lacoste et al., 1985), our findings support the proposition that 
abnormal interhemispheric connectivity may represent a trait marker for BD (Bellani et al., 2009). Little is 
known about the functional role of each sub-region of the CC. However, anterior regions such as the genu 
connect the frontal cortices (Aboitiz et al., 1992) which play an important role in higher order cognitive and 
emotional processing (Davidson and Irwin, 1999, Galinowski et al., 2015). Given the frontal abnormalities 
frequently reported in BD (Phillips, 2014), it is conceivable that microstructural disturbances in the genu of the 
CC may contribute to the cognitive and emotional deficits characteristic of BD. Bearden et al. (Bearden et al., 
2011) has reported a significant association between the genu of the CC and response inhibition, as well as 
verbal processing speed, in BD probands and their unaffected twins. Recent studies have identified associations 
between the genu of the CC and multiple neurocognitive domains including working memory, processing speed 
and psychomotor coordination in BD subjects compared to controls (Ajilore et al., 2015, McKenna et al., 2015, 
Poletti et al., 2015). Taken together, these findings support the postulation that reduced WM integrity in the 
genu of CC in our BD and HR-rMDD subjects may be linked to impulsivity and cognitive disturbances. 
Limitations 
Several methodological issues require consideration. Employment of complementary techniques such as 
tractography, a technique used to visually represent neural tracts, and whole brain voxel based analyses, would 
contribute to a fuller understanding of possible WM microstructural abnormalities in this population. 
Furthermore, while FA is widely accepted to be an index of general WM integrity, specific microstructural 
defects - such as  myelin damage, axonal disorganization, or fiber incoherence - which may underlie changes in 
this metric, remain to be elucidated (Assaf and Pasternak, 2008). Whilst the current study derived average FA 
per tract, the majority of the cited TBSS BD high-risk papers have used voxel-based TBSS or whole brain 
voxel-based analyses, making direct comparison between the present results and previous findings difficult. 
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Further, as the study groups differed on age, we covaried for the potential effects of age, and age x group 
interactions, in our statistical models. In contrast to a report by Versace et al. (2010), we found no evidence of 
age x group interactions in CC FA. However, as typical WM cortical development is non-linear (Imperati et al., 
2011, Lebel et al., 2012) and non-linear effects of age could not be incorporated into our model, we cannot 
exclude the possibility of non-linear effects of age on our findings. 
Our results need to be interpreted with caution given the absence of differences between controls and 
our total cohort of HR subjects (n=150). Although it is likely that a substantial proportion of our high-risk 
individuals with recurrent MDD will develop BD, the time course for this is unknown. With all the current 
participants enrolled in an ongoing longitudinal study, follow-up data will improve our understanding of the 
underlying mechanisms that contribute to trajectories that result in BD. As our MRI scans are repeated at 
multiple time points, in future years we will be able to investigate whether abnormalities in the genu of the CC 
are more frequent in those who subsequently develop BD. Further, in view of recent studies (Bessette et al., 
2014, Xu et al., 2013) and a meta-analysis (Liao et al., 2013) which have reported abnormalities in the genu and 
body of the CC of patients with MDD not at familial risk of BD, it is not possible at present to distinguish 
between our finding representing a specific risk to future BD or a broader generic risk to mood disorders 
including MDD. 
Conclusions 
These results from a large sample provide further evidence that the genu of the CC may play a role in the 
pathophysiology of BD. Furthermore, in a novel finding, we extend previous CC findings by showing that 
lower FA in the genu of the CC was also present in those at high familial risk who have recurrent MDD. While 
it need be acknowledged that the number of those with recurrent MDD was relatively small, and that 
longitudinal data is needed to definitively determine trajectories that result in BD, our findings nonetheless raise 
the tantalising possibility that WM integrity of the CC may represent a potential trait marker for BD. 
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Fig. 1. Group differences in mean FA in the genu of the corpus callosum 
(A) The BD group showed lower FA in the genu of the corpus callosum (CC) compared to HR and CON groups.  FDR corrected group effect and pairwise comparisons.  (B) 
When HR subjects with recurrent MDD (HR-rMDD) (n=16) were selected from our total HR sample (n=150) and compared against the CON and BD groups, the HR-rMDD 
group had reduced FA in the genu of the CC compared to CON subjects. FDR corrected pairwise comparisons. Abbreviations: CON, controls; HR, high risk; HR-rMDD, 
high risk subjects with a lifetime diagnosis of recurrent major depressive disorder; BD, bipolar disorder. Estimated means are reported after covarying for age and gender. * 
p<0.05, **p<0.01. 
Figure(s)
Table 1. Demographic data for control (CON), high risk (HR), and bipolar disorder (BD) groups 
Demographic data HR (n=150) BD (n=63) p-value Pairwise Comparisons 
65 (43.3) 21 (33.3) 0.32 
113.73 (0.96) 116.11 (1.52) 0.05 
12.59 (3.67) 15.48 (2.46) <0.01 
Males, n (%) 
Intelligence Quotient, mean 
(SD) Years of Education, mean 
(SD)  Age, mean (SD) 
CON (n=111) 
49 (44.1)      
117.26 (1.05)   
15.34 (2.77) 
21.83 (3.94)     19.73 (5.59) 24.95  (3.83) 
Difference Statistic 
χ2= 2.25 
F= 3.11 
F=30.95 
F= 27.16 <0.01 
CON>HR p<0.05 
CON>HR p<0.01, BD>HR p<0.01  
CON>HR p<0.01, BD>HR p<0.01, BD>CON p<0.01 
Table(s)
Table 2. Clinical and medication data for control (CON), high risk (HR), and bipolar disorder (BD) groups 
Lifetime DSM-IV diagnosis CON (n=111) HR (n=150) BD (n=63) Difference Statistic p-value Pairwise Comparisons 
Any diagnosis, n (%) 32 (28.8)                   75 (50.0)             63 (100.0)               χ2 = 82.31 <0.01 HR>CON p<0.01  
BD>CON p<0.01 
BD>HR p<0.01 
At least one MDE, n (%) 12 (10.8)  44 (29.3) 60 (95.2) χ2= 131.94 <0.01 HR>CON p<0.01 
BD>CON p<0.01 
BD>HR p<0.01  
Recurrent MDD, n (%) 3 (2.7) 16 (10.7) - χ2= 5.99 0.01 HR>CON, p<0.05 
Any anxiety disorder, n (%) 
12 (11.7) 32 (22.1) 30 (49.2) χ2 = 32.63 
<0.01 
HR>CON p<0.05 
BD>CON p<0.01 
BD>HR p<0.01  
Any behavioural disorder, n (%) 1 (1.0) 16 (11.3) 9 (15.3) χ2 = 13.33 <0.01 HR>CON p<0.01 
BD>CON p<0.01 
Any substance disorder, n (%) 7 (6.3) 13 (18.7) 15 (23.8) χ2 = 14.10 <0.01 BD>CON p<0.01 
BD>HR p<0.01  
Current DSM-IV diagnosis 
MDE, n (%) 2 (1.8) 3 (2.0) 3 (4.8) χ2= 1.61 0.45 
Hypo/manic episode, n (%) 0  (0) 0 (0) 0 (0) - - 
Symptom severity scales 
22 to 30 years     n=54 n=49 n=44 
MADRS, mean (SD) 2.22 (4.05) 3.00 (4.03) 10.68 (10.65) F=21.41 <0.01 
YMRS, mean (SD) 1.00 (1.71) 0.98 (1.51) 4.61 (4.58) F=27.27 <0.01 
BD>CON  p<0.01 
BD>HR p<0.01 
BD>CON  p<0.01 
BD>HR p<0.01 
12 to 21 Years n=37 n=70 n=9 
CDI, mean (SD) 7.13 (4.26) 8.36  (5.98) 19.89  (7.51) F= 19.36 <0.01 BD>CON  p<0.01 
BD>HR p<0.01 
Clinical Characteristics 
Global Functioning 
GAS/C-GAS, mean (SD) 91.01 (5.65) 85.63 (9.88) 78.17 (11.74) F= 38.86 <0.01 CON>HR p<0.01 
CON>BD p<0.01 
HR>BD p<0.01  
Age at First  
MDE, mean (SD) 19.18 (2.96) 16.98 (4.77) 15.45 (3.58) F= 5.95 <0.01 CON>BD p<0.01 
Hypomanic episode, mean (SD) - - 17.96 (4.18) - - - 
Manic episode, mean (SD) - - 19.48 (4.33) - - - 
Elevated mood episode, mean (SD) - - 18.17 (4.21) - - - 
Mood episode, mean (SD) 19.18 (2.96) 16.98 (4.77) 15.26 (3.99) F= 7.11 <0.01 CON>BD p<0.01 
Number of Episodes 
Major depressive episode, mean (SD) 1.41 (1.23) 2.44 (2.82) 11.93 (11.68) F=20.57 <0.01 CON<BD p<0.01 
Hypomanic episodes, mean (SD) - - 10.45 (11.2) - HR<BD p<0.01 
Manic episode, mean (SD) - - 3.13 (2.66) - - 
Any elevated mood episode, mean (SD) - - 9.95 (11.06) - - 
Any mood episode, mean (SD) 1.41 (1.23) 2.44 (2.82) 21.28 (19.87) F= 28.04 <0.01 CON<BD p<0.01 
HR<BD p<0.01 
Current Psychotropic Medication 
At least one psychotropic medication, n (%) 4 (3.6) 11 (8.0) 46 (76.2) 
Anti-depressants, n (%) 3 (2.7) 10 (6.7) 36 (57.1) 
Mood stabilisers, n (%)  - - 39 (61.9) 
Anti-psychotics, n (%) - - 20 (31.7) 
Benzodiazepines, n (%)  - 1 (1.1) 2 (1.26) 
Stimulants, n (%)  1 (1.5) - 1 (0.63) 
Anti-convulsants, n (%)  - - 5 (3.15) 
Abbreviations: MADRS, Montgomery-Asberg Depression Rating Scale; YMRS, Youth mania rating Scale; CDI, Children’s Depression Inventory: CON, controls; HR, high risk; BD, bipolar 
disorder; MDE, Major Depressive Episode; MDD, Major Depressive Disorder; GAS, Global Assessment Scale; C-GAS, Children’s Global Assessment Scale.   All participants had an IQ above 
80. A lifetime major depressive episode is defined as meeting DSM-IV criteria for at least one major depressive episode.  Confidence rating ranges using the Best Estimate Methodology vary 
from 1-4, where 1 represents criteria not met for a diagnosis and 4 represents a definite diagnosis. All diagnoses listed here have a confidence rating of 3 or higher (i.e. probable or definite). 
Among the thirteen participants with a behavioural disorder, ten had attention-deficit hyperactivity disorder (five current), three had oppositional defiant disorder (one current) and three had 
conduct disorder (none current).  The average age of onset of recurrent or single episode MDD in our sample was 17.9 (SD 5.0) in the HR group, 19.1 (2.9) in controls and 15.1 (2.8) in the BD 
group. For anxiety disorders, the figures were 12.7 (6.5), 11.3 (6.7) and 12.5 (6.1) respectively. Of the 39 BD participants taking a mood stabiliser, 15 were taking lithium 
Supplementary Methods 
Participants 
Only one acquisition was collected from ten participants and included in the analysis (five CON, 
three HR, and two BD). Six additional participants (two CON, three HR, and one BD) were removed 
because of poor contrast. 
Diffusion tensor imaging pre-processing 
DTI data were pre-processed offline on a Linux system-based workstation using the FMRIB's 
Diffusion Toolbox (FDT), which is a part of the FMRIB's Software Library (FSL) (version 5.0)56. 
First, each subject’s raw DTI data were visually inspected to exclude any severe head movements 
and DTI artefacts. Second, both acquisitions were merged and each subject was corrected for eddy 
current and head motion by registering each participant's 6 diffusion weighted images to their own 
T2-weighted (b = 0) image using an affine image registration (FLIRT). A binary brain mask was 
created to remove the non-brain tissue using the Brain Extraction Tool (BET) in FSL. Then, 
diffusion tensor was reconstructed by fitting a diffusion tensor model to each image voxel of the pre-
processed DTI data in ICBM diffusion space, using the DTIfit program included in FSL. Following 
this, the fractional anisotropy (FA) map was calculated and visually inspected for each participant. 
DTI skeletonization and ROI extraction from FA images 
In sum, the FA images were non-linearly mapped onto the ENIGMA-DTI FA template to project the 
skeleton using FSL fnirt (Smith et al., 2007, Smith et al., 2006). Rather than employing the 
ENIGMA templates provided, registered images from our dataset were combined to create a mask 
and distance map. Images were visually inspected to ensure FA maps were registered. Images were 
aligned to the DTI template in ICBM space and mean FA in regions of interest  (ROIs) were 
extracted from the skeletal projections using the TBSS analytic method (Smith et al., 2007, Smith et 
Other Supplementary Material
al., 2006), where ROIs, were derived from the Johns Hopkins University (JHU) white matter 
parcellation atlas (Mori et al., 2008). 
The full brain mean FA values were calculated to include all voxels in the ENIGMA-DTI skeleton, 
not just those voxels in the segmented regions of interest, therefore also including peripheral white 
matter. This type of analysis has been used previously in both genetics studies and disease related 
studies (Nir et al., 2013, Kochunov et al., 2011, Jahanshad et al., 2013). 
Table S1 Index of regions of interest (ROIs) from the JHU DTI atlas 
 ROIs  Abbreviation 
ACR-L,R Anterior corona radiata 
ALIC-L,R Anterior limb of internal capsule 
CGC-L,R Cingulum (cingulate gyrus) 
CGH-L,R Cingulum (hippocampus) 
CP-L,R Cerebral peduncle 
CST-L,R Corticospinal tract 
EC-L,R External capsule 
FX/ST-L,R Fornix (cres) / Stria terminalis 
GCC Genu of corpus callosum 
ICP-L,R Inferior cerebellar peduncle 
ML-L,R Medial lemniscus 
PCR-L,R Posterior corona radiata 
PLIC-L,R Posterior limb of internal capsule 
PTR-L,R Posterior thalamic radiation (include optic radiation) 
RLIC-L,R Retrolenticular part of internal capsule 
SCP-L,R Superior cerebellar peduncle 
SCR-L,R Superior corona radiata 
SFO-L,R Superior fronto-occipital fasciculus (could be a part of anterior internal capsule) 
SLF-L,R Superior longitudinal fasciculus 
SS-L,R Sagittal stratum (include inferior longitidinal fasciculus and inferior fronto-occipital fasciculus) 
Tap-L,R Tapetum 
UNC-L,R Uncinate fasciculus 
BCC Body of corpus callosum 
FX Fornix (column and body of fornix) 
SCC Splenium of corpus callosum 
Abbreviations: L, left; R, right.
Table S2 Between-Group Effects 
CON HR BD Covariates: Age and Gender 
Mean (SEM) Mean (SEM) Mean (SEM) p FDR q post hoc 
ACR 0.465 (0.003) 0.470 (0.003) 0.463 (0.004) 0.113 0.021 na 
ALIC 0.567 (0.003) 0.571 (0.003) 0.567 (0.004) 0.423 0.037 na 
BCC+ 0.648 (0.004) 0.642 (0.004) 0.637 (0.005) 0.081 0.019 na 
CGC 0.587 (0.004) 0.581 (0.004) 0.578 (0.006) 0.229 0.029 na 
CGH 0.555 (0.006) 0.544 (0.005) 0.554 (0.008) 0.162 0.023 na 
CP 0.735 (0.003) 0.735 (0.003) 0.730 (0.003) 0.309 0.033 na 
CST 0.595 (0.005) 0.600 (0.005) 0.595 (0.007) 0.864 0.046 na 
EC 0.461 (0.003) 0.461 (0.003) 0.460 (0.003) 0.943 0.048 na 
FX+ 0.531 (0.006) 0.532 (0.007) 0.530 (0.009) 0.980 0.050 na 
FX_ST 0.572 (0.004) 0.569 (0.004) 0.565 (0.005) 0.476 0.038 na 
GCC+ 0.699 (0.003) 0.696 (0.003) 0.687 (0.004)    0.014*A 0.014 BD<HR p=0.03, BD<CON p=0.003*A 
ICP 0.593 (0.005) 0.594 (0.004) 0.581 (0.005)  0.030B 0.015 na 
ML 0.666 (0.005) 0.668 (0.005) 0.661 (0.005) 0.559 0.040 na 
PCR 0.510 (0.003) 0.510 (0.003) 0.510 (0.004) 0.941 0.048 na 
PLIC 0.692 (0.003) 0.695 (0.003) 0.692 (0.003) 0.519 0.040 na 
PTR 0.661 (0.004) 0.655 (0.005) 0.651 (0.005) 0.172 0.026 na 
RLIC 0.607 (0.003) 0.614 (0.003) 0.613 (0.004) 0.155 0.020 na 
SCC+ 0.768 (0.003) 0.768 (0.003) 0.762 (0.003) 0.185 0.026 na 
SCP 0.650 (0.004) 0.645 (0.004) 0.643 (0.004) 0.385 0.036 na 
SCR 0.500 (0.002) 0.4982 (0.002) 0.498 (0.003) 0.634 0.043 na 
SFO 0.511 (0.003) 0.512 (0.003) 0.511 (0.004) 0.958 0.049 na 
SLF 0.514 (0.002) 0.513 (0.003) 0.510 (0.003) 0.238 0.030 na 
SS# 0.572 (0.003) 0.571 (0.004) 0.565 (0.005) 0.317 0.018 na 
TAP 0.577 (0.006) 0.566 (0.006) 0.559 (0.008) 0.041B 0.015 na 
UNC 0.544 (0.005) 0.537 (0.005) 0.538 (0.006) 0.342 0.035 na 
Average FA 0.465 (0.002) 0.465 (0.002) 0.461 (0.002) 0.156 n/a na 
+ represents inter-hemispheric regions. B represents effects that were significant (p<0.05) prior to correcting for multiple tests. *A effects that survive FDR correction at a 
threshold of p<0.05 (p-values that are smaller than their corresponding q-vakue survived FDR correction). #= only variable where age*group was included as an extra 
interaction as p<0.05 for this interaction. Abbreviations: CON, controls; HR, high risk; BD, bipolar disorder; na, not-applicable.  Estimated means are reported covarying for 
age and gender.  
Table S3 Hemisphere Effects 
Right Left 
Mean (SEM) Mean (SEM) p FDR q Direction 
ACR 0.470 (0.002) 0.463 (0.002) <0.001* 0.010 R > L 
ALIC 0.569 (0.002) 0.568 (0.002) 0.213 0.028 na 
CGC 0.565 (0.004) 0.599 (0.004) <0.001* <0.001 R < L 
CGH 0.571 (0.005) 0.531 (0.005) <0.001* <0.001 R > L 
CP  0.745 (0.003) 0.722 (0.002) <0.001* 0.002 R > L 
CST 0.598 (0.005) 0.594 (0.005) 0.076 0.019 na 
EC 0.456 (0.002) 0.464 (0.002) <0.001* 0.008 R < L 
FX_ST 0.576 (0.004) 0.562 (0.003) <0.001* 0.007 R < L 
ICP 0.594 (0.004) 0.585 (0.004) <0.001* 0.007 R > L 
ML  0.669 (0.004) 0.661 (0.004) <0.001* 0.009 R > L 
PCR 0.516 (0.003) 0.504 (0.002) <0.001* 0.003 R > L 
PLIC 0.706 (0.002) 0.681 (0.002) <0.001* 0.004 R > L 
PTR 0.662 (0.004) 0.649 (0.004) <00.01* 0.006 R > L 
RLIC 0.611 (0.003) 0.611 (0.003) 0.877 0.050 na 
SCP 0.648 (0.005) 0.649 (0.004) <0.001* 0.012 R > L 
SCR 0.497 (0.002) 0.500 (0.002) 0.001* 0.012 R < L 
SFO 0.515 (0.003) 0.508 (0.003) <0.001* 0.011 R > L 
SLF 0.513 (0.002) 0.511 (0.002) 0.006* 0.013 ns 
SS# 0.578 (0.003) 0.561 (0.003) <0.001* 0.005 R > L 
TAP 0.606 (0.006) 0.528 (0.005) <0.001* 0.004 R > L 
UNC 0.545 (0.004) 0.535 (0.045) <0.001* 0.010 R > L 
*denotes effects that survive FDR correction at a threshold of P<0.05 (p-values that are smaller than their corresponding q-value survived FDR correction). #= only variable
where age*group was included as an extra interaction as p<0.05 for this interaction. Abbreviations: ns, non-significant; na, not-applicable. Estimated means are reported 
covarying for age and gender. 
Right hemisphere lateralisation was evident in 13 ROIs and left hemisphere lateralisation was identified in 4 ROIs. Our interhemispheric 
findings are in accord with a number of previous reports including rightward asymmetry of the anterior and posterior corona radiata, uncinate 
fasciculus, parts of the posterior thalamic radiation, medial lemniscus, and the posterior limb of the internal capsule (Takao et al., 2011a, Takao 
et al., 2011b, Takao et al., 2013, Yin et al., 2013), and leftward lateralisation in areas of the external capsule and cingulum (Gong et al., 2005, 
Takao et al., 2013). As the brain is asymmetric in function (Barrick et al., 2007) and as asymmetry is influenced by a variety of factors such as 
genes and hormones (Toga and Thompson, 2003), patterns are difficult to interpret and disentangle. 
Table S4 Group x Hemisphere Interaction 
CON Left CON Right HR Left HR Right BD Left BD Right Covariates: Age and Gender 
Mean (SEM) Mean (SEM) Mean (SEM) Mean (SEM) Mean (SEM) Mean (SEM) p FDR q 
post hoc 
within 
hemisphere 
post hoc 
between 
hemisphere 
ACR 0.463 (0.003) 0.468 (0.003) 0.468 (0.003) 0.473 (0.003) 0.458 (0.004) 0.467 (0.004) 0.269 0.032 na na 
ALIC 0.566 (0.003) 0.569 (0.003) 0.571 (0.003) 0.571 (0.003) 0.567 (0.004) 0.567 (0.004) 0.274 0.032 na na 
CGC 0.603 (0.005) 0.571 (0.005) 0.598 (0.005) 0.564 (0.004) 0.595 (0.006) 0.561 (0.006) 0.848 0.045 na na 
CGH 0.536 (0.006) 0.574 (0.006) 0.527 (0.006) 0.562 (0.006) 0.531 (0.008) 0.577 (0.009) 0.239 0.031 na na 
CP 0.724 (0.003) 0.746 (0.003) 0.725 (0.003) 0.746 (0.004) 0.718 (0.004) 0.742 (0.004) 0.328 0.034 na na 
CST 0.591 (0.006) 0.598 (0.006) 0.596 (0.006) 0.600 (0.006) 0.594 (0.007) 0.596 (0.007) 0.611 0.042 na na 
EC 0.463 (0.003) 0.460 (0.003) 0.464 (0.003) 0.459 (0.002) 0.463 (0.003) 0.458 (0.003) 0.562 0.041 na na 
FX_ST 0.567 (0.004) 0.576 (0.004) 0.563 (0.004) 0.576 (0.005) 0.555 (0.005) 0.576 (0.06) 0.092 0.021 na na 
ICP 0.587 (0.004) 0.599 (0.005) 0.589 (0.005) 0.600 (0.004) 0.577 (0.005) 0.584 (0.005) 0.440 0.037 na na 
ML  0.662 (0.005) 0.671 (0.005) 0.663 (0.005) 0.673 (0.005) 0.659 (0.006) 0.663 (0.005) 0.168 0.025 na na 
PCR 0.501 (0.003) 0.517 (0.003) 0.505 (0.003) 0.516 (0.003) 0.504 (0.003) 0.515 (0.004) 0.050 0 .017 na na 
PLIC 0.681 (0.003) 0.704 (0.003) 0.683 (0.003) 0.708 (0.003) 0.679 (0.003) 0.706 (0.003) 0.332 0.035 na na 
rPTR 0.654 (0.005) 0.668 (0.004) 0.646 (0.005) 0.664 (0.005) 0.647 (0.005) 0.655 (0.006) 0.150 0.023 na na 
RLIC 0.608 (0.003) 0.607 (0.004) 0.612 (0.004) 0.616 (0.004) 0.614 (0.004) 0.611 (0.005) 0.163 0.020 na na 
SCP 0.648 (0.004) 0.651 (0.004) 0.645 (0.004) 0.646 (0.004) 0.639 (0.005) 0.646 (0.005) 0.068 0.018 na na 
SCR 0.501 (0.003) 0.499 (0.002) 0.500 (0.002) 0.496 (0.002) 0.499 (0.003) 0.497 (0.003) 0.477 0.039 na na 
SFO 0.507 (0.004) 0.515 (0.003) 0.510 (0.004) 0.513 (0.003) 0.506 (0.005) 0.516 (0.004) 0.196 0.027 na na 
SLF 0.513 (0.002) 0.515 (0.003) 0.512 (0.003) 0.514 (0.003) 0.507 (0.003) 0.510 (0.003) 0.708 0.043 na na 
SS# 0.563 (0.004) 0.580 (0.004) 0.563 (0.004) 0.580 (0.004) 0.557 (0.005) 0.573 (0.005) 0.961 0.047 na na 
TAP 0.537 (0.007) 0.617 (0.007) 0.527 (0.006) 0.604 (0.006) 0.520 (0.008) 0.597 (0.009) 0.847 0.044 na na 
UNC 0.540 (0.005) 0.549 (0.005) 0.534 (0.005) 0.540 (0.006) 0.531 (0.007) 0.546 (0.006) 0.228 0.029 na na 
No group*hemisphere were evident at a threshold of p<0.05 uncorrected. Abbreviations: CON, controls; HR, high risk; BD, bipolar disorder; na, non-applicable; Estimated 
means are reported covarying for age and gender. 
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